Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 1c, Revenues Beat

Go back to Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 1c, Revenues Beat

Zimmer Biomet (ZBH) PT Raised to $127 at Canaccord Genuity

April 26, 2019 1:27 PM EDT

Canaccord Genuity analyst Kyle Rose raised the price target on Zimmer Biomet (NYSE: ZBH) to $127.00 (from $125.00) while maintaining a Hold rating.

executing to plan but still early in the process... More

Zimmer Biomet (ZBH) PT Raised to $134 at RBC Capital

April 26, 2019 11:45 AM EDT

RBC Capital analyst Brandon Henry raised the price target on Zimmer Biomet (NYSE: ZBH) to $134.00 (from $128.00) while maintaining a Outperform rating following results.

Long-Term Turnaround Story Unchanged;... More

Needham & Company Upgrades Zimmer Biomet (ZBH) to Strong Buy

April 24, 2019 6:06 AM EDT

Needham & Company analyst Mike Matson upgraded Zimmer Biomet (NYSE: ZBH) from Buy to Strong Buy with a price target of $155.00.

The analyst comments "We expect ZBHs revenue growth to accelerate during 2019 as it shifts back to offense after addressing its supply... More